These results revealed that APS can exert its anti-hypertrophic action via inhibiting Ca2+-mediated calcineurin/NFATc3 and CaMKII signaling cascades in isoproterenol-induced cardiac hypertrophy rats [71] (Figure 12). Here, CAMK2G is linked to cardiac hypertrophy.